Virtual
May 19–21, 2021

Past Forum: 2019

Boston

Summary

The 2019 World Medical Innovation Forum will focus on Artificial Intelligence (AI) and its growing impact on clinical care.

This meeting brought together global leaders in the emerging discipline of artificial intelligence and machine learning for in-depth conversations on the fast-developing novel technologies that characterize the early era of adoption. Impact on patients, clinicians and systems were examined in depth. The Forum panels, consisting of industry and investment executives, teamed with Harvard clinical and research leaders, focused on patient interactions across care settings, and the role technology and data can play in advancing knowledge discovery and care delivery.

Keynoters

Peter Orszag, PhD

Peter Orszag, PhD  

  • Vice Chairman, Corporate and Investment Banking, Citigroup
Secretary Alex Azar

Honorable Alex Azar II  

  • Secretary of Health and Human Services,
Ashton B. Carter

Ash Carter  

  • U.S. Secretary of Defense, 2015–2017
Simon Stevens

Simon Stevens  

  • CEO, NHS England

Stefan Oelrich  

  • Member of the Board of Management, Bayer AG
  • President, Pharmaceutical, Bayer AG

Nisa Leung  

  • Managing Partner, Qiming Venture Partners

Amy Abernethy, MD, PhD  

  • Deputy Commissioner, FDA

Mark Benjamin  

  • CEO, Nuance Communications
Diana Nole

Diana Nole  

  • CEO, Wolters Kluwer Health
James Weinstein, DO

James Weinstein, DO  

  • SVP, Head of Innovation and Health Equity, Microsoft Healthcare

Kieran Murphy  

  • CEO, GE Healthcare

Nancy Brown  

  • CEO, American Heart Association
Vivian Lee, MD, PhD

Vivian Lee, MD, PhD  

  • President, Health Platforms, Verily Life Sciences
Dawn Barry

Dawn Barry  

  • President and Co-Founder, LunaDNA
Robert Bradway

Robert Bradway  

  • CEO, Amgen
Seema Verma

Seema Verma  

  • Administrator, Centers for Medicare and Medicaid Services

Bernd Montag, PhD  

  • CEO, Siemens Healthineers
Frans van Houten

Frans Van Houten  

  • CEO, Philips
Jensen Huang

Jensen Huang  

  • CEO, NVIDIA

Panels

Day One: Monday, April 8, 2019

Early career Harvard Medical School investigators kicked-off the World Medical Innovation Forum with rapid fire presentations of their high potential new technologies. Eighteen rising stars from Brigham Health and Massachusetts General Hospital highlighted the potential of their research in artificial intelligence, cognitive computation, machine learning, and big data in ten minute presentations. This session was designed for investors, entrepreneurs, investigators, donors and others who share a passion for accelerating the application of high impact technologies to the benefit of patients.

Discovery Café: Applying AI to Save Lives During the Opioid Crisis 

  • Moderator: Thomas Sequist, MD, Chief Quality & Safety Officer, PHS 
  • Bob Burgin, CEO, Amplifire Healthcare Alliance
  • Carm Huntress, CEO, RxRevu Inc
  • Sarah Wakeman, MD, Medical Director, Substance Use Disorder Initiative, MGH; Assistant Professor, Medicine, HMS
  • Scott Weiner, MD, Director, Brigham Comprehensive Opioid Response and Education (B-CORE) Program, BH; Assistant Professor, HMS

Discovery Café: Community Hospitals: Key Component in Healthcare Transformation 

  • Moderator: Michael Jaff, DO, President, NWH, PHS, Professor of Medicine, HMS
  • Fabien Beckers, PhD, CEO, Arterys
  • Joanna Geisinger, CEO, TORq Interface
  • John Miller, MD, Director, Retinal Imaging, MEE; Assistant Professor, Ophthalmology, HMS
  • Lee Schwamm, MD, Director, Center for TeleHealth and Exec Vice Chair, Neurology, MGH; Professor, Neurology, HMS
  • Tal Wenderow, CEO, Beyond Verbal

Discovery Café: Digital Management of Diabetes 

  • Moderator: Deborah Wexler, MD, Clinical Director, Diabetes Center, MGH; Associate Professor, HMS
  • Marie McDonnell, MD, Section Chief and Director, Diabetes Program, BH; Lecturer, HMS
  • Michael Meissner, PhD, CTO and VP, MED, Sanofi
  • Joshua Riff, MD, CEO, Onduo
  • Marie Schiller, VP, Connected Care and Insulins Product Development and Site Head, Cambridge Innovation Center, Eli Lilly

Discovery Café: AI and Its Impact on the Future of Emergency Care

  • Moderator: Adam Landman, MD, VP and CIO, BH; Associate Professor of Emergency Medicine, HMS
  • Peter Chai, MD, Assistant Professor, Emergency Medicine, BH, HMS
  • Emily Hayden, MD, Attending Physician, Emergency Medicine, MGH; Instructor, Surgery, HMS
  • Kohei Hasegawa, MD, Attending Physician, Emergency Medicine, MGH; Associate Professor, Emergency Medicine, HMS
  • Sean Kelly, MD, CMO, Imprivata; Assistant Professor, Emergency Medicine, HMS
  • Bijoy Sagar, VP, Chief Digital Technology Officer, Stryker

Discovery Café: Mental Health, Smartphone Apps and the Promise of AI 

  • Moderator: Sabine Wilhelm, PhD, Chief of Psychology; Director, OCD and Related Disorders Program, MGH; Professor, Psychology, HMS
  • Jennifer Gentile, PsyD, SVP, US Clinical Operations, Ieso Digital Health
  • Thomas McCoy, MD, Director of Research, Center for Quantitative Health, MGH; Assistant Professor, Psychiatry and Medicine, HMS
  • Christopher Molaro, CEO, Neuroflow
  • David Silbersweig, MD, Chairman, Department of Psychiatry, BH; Stanley Cobb Professor of Psychiatry, HMS
  • Jeremy Sohn, VP, Global Head of Digital Business Development and Licensing , Novartis

Discovery Café: From Startup to Impact (Pharma and Diagnostics) 

  • Moderator: James Brink, MD, Radiologist-in-Chief, MGH; Juan M. Taveras Professor of Radiology, HMS
  • Moderator: James Nicholls, Managing Director, Fitzroy Health
  • Sarah Beeby, EVP, GM Lifesciences, Clinithink
  • Charles Cadieu, PhD, CEO, Bay Labs
  • JB Michel, PhD, SVP Data Science & GM USA, BenevolentAI
  • Art Papier, MD, CEO, VisualDx
  • Alex Zhavoronkov, PhD, CEO, Insilico Medicine, Inc

AI Strategy: AI from the Top 

  • Moderator: Susan Hockfield, PhD, Board Member, PHS; President Emerita and Professor of Neuroscience, MIT
  • Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
  • Alistair Erskine, MD, Chief Digital Health Officer, PHS
  • Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2019 Forum Co-Chair

1:1 Fireside Chat: Jensen Huang, CEO, NVIDIA 

  • Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
  • Jensen Huang, CEO, NVIDIA

Remarks: The Honorable Charlie Baker 

  • Introduction: Scott Sperling, Co-President, Thomas H. Lee Partners; Chairman of the Board of Directors, PHS
  • The Honorable Charlie Baker, Governor of the Commonwealth of Massachusetts

RWE and Trial Optimization in the AI Era

  • Moderator: Thomas Lynch, MD, EVP and CSO, R&D, Bristol-Myers Squibb
  • Amy Abernethy, MD, PhD, Deputy Commissioner, FDA
  • Michael Devoy, MD, EVP MA&PV and Bayer CMO, Bayer AG
  • Josh Mandel, MD, Chief Architect, Microsoft Healthcare
  • Vicki Seyfert-Margolis, PhD, CEO, My Own Med Inc.
  • Stephen Wiviott, MD, Executive Director, Clinical Trials Office, PHS; Associate Professor of Medicine, HMS
AI Driven Value-Based Care 
  • Moderator: Timothy Ferris, MD, CEO, MGPO; Professor of Medicine, HMS
  • Nancy Brown, CEO, American Heart Association
  • Kris Joshi, PhD, EVP, President, Network Solutions, Change Healthcare
  • Simon Stevens, CEO, NHS England

Cardiovascular Care: Reinvented Through AI 

  • Moderator: Calum MacRae, MD, PhD, Vice Chair for Scientific Innovation, Department of Medicine, BH; Associate Professor of Medicine, HMS
  • Heather Bell, PhD, SVP, Global Head of Digital and Analytics, Sanofi
  • Mike Burke, Patient, Independent Recording Engineer, Burke Recording
  • Sebastian Guth, PhD, President, Bayer Pharma Americas Region, Bayer
  • Udo Hoffmann, MD, Chief Cardiovascular Imaging, MGH; Professor, Radiology, HMS
  • Rahul Patel, EVP/GM, Healthcare and Life Sciences, Persistent Systems

1:1 Fireside Chat: Seema Verma, Administrator, Centers for Medicare & Medicaid Services

  • Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS
  • Seema Verma, Administrator, Centers for Medicare and Medicaid Services

Day Two: Tuesday, April 9, 2019

Implementing AI in Cancer Care 

  • Moderator: Constance Lehman, MD, PhD, Chief, Breast Imaging Division, MGH; Professor of Radiology, HMS
  • Dawn Barry, President and Co-Founder, LunaDNA
  • Regina Barzilay, PhD, Delta Electronics Professor, Electrical Engineering and Computer Science Department, MIT
  • Gad Getz, PhD, Director, Cancer Genome Analysis, Broad Institute; Professor, Pathology, HMS
  • Daphne Koller, PhD, CEO, insitro

Imagining Medicine in the Year 2054 

  • Moderator: Keith Flaherty, MD, Director, Clinical Research, Cancer Center, MGH; Professor of Medicine, HMS
  • Noubar Afeyan, PhD, CEO, Flagship Pioneering
  • Calum MacRae, MD, PhD, Vice Chair for Scientific Innovation, Department of Medicine, BH; Associate Professor of Medicine, HMS
  • Marcela Maus, MD, PhD, Director, Cellular Immunotherapy Program, Cancer Center, MGH; Assistant Professor, Medicine, HMS
  • Rudolph Tanzi, PhD, Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS

1:1 Fireside Chat: Ash Carter, U.S. Secretary of Defense (2015–2017) 

  • Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2019 Forum Co-Chair
  • Ash Carter, U.S. Secretary of Defense (2015–2017)

1:1 Fireside Chat: Honorable Alex Azar II, Secretary of Health and Human Services

  • Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2019 Forum Co-Chair
  • Honorable Alex Azar II, Secretary of Health and Human Services

CEO Roundtable

  • Moderator: Anne Klibanski, MD, Interim President and CEO, Chief Academic Officer, PHS; Laurie Carrol Guthart Professor of Medicine, HMS; 2019 Forum Co-Chair
  • Frans Van Houten, CEO, Philips
  • Joerg Moeller, MD, PhD, EVP, Head, Pharmaceuticals Research and Development, Bayer AG
  • Bernd Montag, PhD, CEO, Siemens Healthineers
  • Kieran Murphy, CEO, GE Healthcare

IDG Program Announcement and Winners

The Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength and accelerate commercialization of PHS intellectual assets. In 2018, the IDG program funded projects that focused on the advancement of opportunities where artificial intelligence can be used to improve clinical care.

Discovery Café: Provider Back Office of the Future

  • Moderator: Peter Markell, EVP, Administration and Finance, CFO and Treasurer, PHS
  • Ingeborg Garrison, CNO/VP of Strategic Advisory Services, Verge Health
  • Kent Ivanoff, CEO, VisitPay
  • Mary Beth Remorenko, VP, Revenue Cycle Operations, PHS
  • Brian Robertson, CEO, VisiQuate

Discovery Café: Chief Digital Strategy Officer Roundtable

  • Moderator: Alistair Erskine, MD, Chief Digital Health Officer, PHS
  • Michael Anderes, Chief Innovation and Digital Health Officer, Froedtert Health; President, Inception Health
  • Adam Landman, MD, VP and CIO, BH; Associate Professor of Emergency Medicine, HMS
  • Aimee Quirk, CEO, innovationOchsner
  • Richard Zane, MD, Chief Innovation Officer, UCHealth; Professor and Chair, Department of Emergency Medicine, University of Colorado School of Medicine

Discovery Café: Innovation Fellows: A New Model of Collaboration

  • Moderator: Seema Basu, PhD, Market Sector Leader, Innovation, PHS
  • Nathalie Agar, PhD, Research Scientist, Neurosurgery, BH; Associate Professor, Neurosurgery, Radiology, HMS
  • Paul Anderson, MD, PhD, Chief Academic Officer, BH; SVP, Research, BH; K. Frank Austen Professor of Medicine, HMS
  • Laurie Braun, MD, Partners Innovation Fellow, MGH and Boston Pharmaceuticals; Instructor in Pediatrics, HMS
  • David Chiang, MD, PhD, Research Fellow, BH; Innovation Fellow, Boston Scientific
  • David Feygin, PhD, Chief Digital Health Officer, Boston Scientific
  • Peter Ho, MD, PhD, CMO, Boston Pharmaceuticals
  • Harry Orf, PhD, SVP, Research, MGH; Principal Associate, HMS

Discovery Café: Last Mile: Fully Implementing AI in Healthcare

  • Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
  • Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, Radiology, HMS
  • Samuel Aronson, Executive Director, IT, Personalized Medicine, PHS
  • Peter Durlach, SVP, Healthcare Strategy & New Business Development, Nuance
  • Seth Hain, VP of R&D, Epic
  • Jonathan Teich, MD, PhD, Chief Medical Information Officer, InterSystems; Emergency Medicine, BH

Discovery Café: Reimagining Disease Management

  • Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS
  • Murray Brozinsky, Chief Strategy Officer, Conversa
  • Jean Drouin, MD, CEO, Clarify Health Solutions
  • Julian Harris, MD, President, CareAllies
  • Erika Pabo, MD, Chief Health Officer, Humana Edge; Associate Faculty, Ariadne Labs; Associate Physician, BH; Instructor, HMS

Discovery Café: Standards and Regulation: The Emerging AI Framework

  • Moderator: Brent Henry, Member, Mintz Levin
  • Bethany Hills, Member/Chair, FDA Practice, Mintz Levin
  • Michelle McMurry-Heath, MD, PhD, VP, Global Regulatory Affairs and International Clinical Evidence, Johnson & Johnson Medical Devices
  • Bakul Patel, Associate Director, Digital Health, FDA
  • Michael Spadafore, Managing Director, Sandbox Industries

Discovery Café: From Startup to Impact (Provider Solutions)

  • Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS
  • Moderator: James Stanford, Managing Director, Fitzroy Health
  • William Grambley, COO, AllazoHealth
  • Gal Salomon, CEO, CLEW
  • Brian Symmons, COO, Gauss Surgical
  • Pelu Tran, CEO, Ferrum Health
  • Ed Zecchini, CIO, Remedy Partners

China: AI Enabled Healthcare Leadership

  • Moderator: James Bradner, MD, President, Novartis Institutes for BioMedical Research
  • Terri Bresenham, Chief Innovation Officer, GE Healthcare
  • Kuan Chen, CEO, Infervision
  • Rujing Gong, Chairman and Co-Founder, Yidu Cloud
  • Nisa Leung, Managing Partner, Qiming Venture Partners
  • Jian Wu, PhD, CEO, Real Doctor Corporation Limited

1:1 Fireside Chat: Mark Benjamin, CEO, Nuance

  • Moderator: Peter Slavin, MD, President, MGH; Professor, Health Care Policy, HMS
  • Mark Benjamin, CEO, Nuance Communications

Getting to the AI Investment Decision

  • Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS
  • Roger Kitterman, VP, Venture and Managing Partner, Partners Innovation Fund, PHS
  • Adam Koppel, MD, PhD, Managing Director, Bain Capital Life Sciences
  • Amir Nashat, PhD, Managing Partner, Polaris Partners
  • Mike Nohaile, PhD, SVP, Strategy, Commercialization and Innovation, Amgen
  • Jim Sinclair, Managing Director, Healthcare Group, Goldman Sachs
  • Krishna Yeshwant, MD, Partner, GV; Instructor in Medicine, BH

1:1 Fireside Chat: Robert Bradway, CEO, Amgen

  • Moderator: Jean-François Formela, MD, Partner, Atlas Venture
  • Robert Bradway, CEO, Amgen

Day Three: Wednesday, April 10, 2019

Innovation Discovery Grant Awardee Presentations

  • Moderator: David Louis, MD, Pathologist-in-Chief, MGH; Benjamin Castleman Professor of Pathology, HMS 
  • Moderator: Clare Tempany, MD, Vice-Chair, Radiology Research, BH; Ferenc Jolesz MD Professor of Radiology, HMS

1:1 Fireside Chat: Stefan Oelrich, Bayer AG

  • Moderator: Betsy Nabel, MD, President, Brigham Health; Professor of Medicine, HMS
  • Stefan Oelrich, Member of the Board of Management, Bayer AG; President, Pharmaceutical, Bayer AG

1:1 Fireside Chat: Deepak Chopra, MD, Founder, The Chopra Foundation

  • Moderator: Rudolph Tanzi, PhD, Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
  • Deepak Chopra, MD, Founder, The Chopra Foundation

Using AI to Predict and Monitor Human Performance and Neurological Disease

  • Moderator: Merit Cudkowicz, MD, Chief of Neurology, Co-Director, Neurological Clinical Research Institute, MGH; Julieanne Dorn Professor of Neurology, HMS
  • Poppy Crum, PhD, Chief Scientist, Dolby Laboratories
  • Husseini Manji, MD, Global Therapeutic Head, Neuroscience Janssen Research & Development
  • Alfred Sandrock, MD, PhD, EVP and CMO, Biogen
  • Isaac Galatzer-Levy, PhD, Vice President of Clinical and Computational Neuroscience, AiCure; Assistant Professor of Psychiatry, NYU School of Medicine

Disruptive Dozen: 12 Technologies That Will Reinvent AI in the Next 12 Months

  • Moderator: Jeffrey Golden, MD, Chair, Department of Pathology, BH; Ramzi S. Cotran Professor of Pathology, HMS 
  • Moderator: Erica Shenoy, MD, PhD, Associate Chief, Infection Control Unit, MGH; Assistant Professor, Medicine, HMS

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA